AIM: To investigate the expression and clinical significance of DEK, cyclin D1, insulin-like growth factor II (IGF-II), glypican 3 (GPC3), ribosomal phosphoprotein 0 (rpP0) mRNA in hepatocellular carcinoma (HCC) and its paraneoplastic tissues. METHODS: The expression of mRNAs of DEK, cyclin D1, IGF-II, GPC3 and rpP0 mRNA was detected in HCC and its paraneoplastic tissues by multiplex RT-PCR. RESULTS: By the simplex RT-PCR, the overexpression of mRNAs of DEK, cyclin D1, IGF-II, GPC3, rpP0 mRNA in HCC and its paraneoplastic tissues was 78.1%, 87.5%, 87.5%, 75.0%, 81.3 % and 15.6%, 40.6%, 37.5%, 21.9%, 31.3 % respectively (P<0.05). By the multiplex RT-PCR, at least one of the mRNAs was detected in all HCC sample
Objective Hepatocellular carcinoma (HCC) is a common cancer with a high mortality rate; the molecula...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of hepatitis B...
Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. Hepatitis B virus (HBV) or hep...
To investigate the expression of four hepatocellular cancer antigen (HCA) gene mRNA in hepatocellula...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Background/Aims: Hepsin is a type II transmembrane protein predominantly expressed in the liver and ...
Hepatocellular carcinoma (HCC) is one of the major causes of cancer deaths worldwide. New diagnostic...
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and it represents a major...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is a deadly cancer, whose incidence is increasing worldwide. Albeit t...
AIM: To investigate the expression of cysteine-rich61 (Cyr61), connective tissue growth factor (CTGF...
Objective Hepatocellular carcinoma (HCC) is a common cancer with a high mortality rate; the molecula...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of hepatitis B...
Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. Hepatitis B virus (HBV) or hep...
To investigate the expression of four hepatocellular cancer antigen (HCA) gene mRNA in hepatocellula...
Objective: Various treatments have greatly reduced the mortality of hepatocellular carcinoma (HCC). ...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in the world. T...
Background/Aims: Hepsin is a type II transmembrane protein predominantly expressed in the liver and ...
Hepatocellular carcinoma (HCC) is one of the major causes of cancer deaths worldwide. New diagnostic...
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and it represents a major...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is a deadly cancer, whose incidence is increasing worldwide. Albeit t...
AIM: To investigate the expression of cysteine-rich61 (Cyr61), connective tissue growth factor (CTGF...
Objective Hepatocellular carcinoma (HCC) is a common cancer with a high mortality rate; the molecula...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...